334 related articles for article (PubMed ID: 7023363)
1. The proteolytic activation systems of complement.
Reid KB; Porter RR
Annu Rev Biochem; 1981; 50():433-64. PubMed ID: 7023363
[No Abstract] [Full Text] [Related]
2. The biochemistry of complement.
Porter RR; Reid KB
Nature; 1978 Oct; 275(5682):699-704. PubMed ID: 703835
[TBL] [Abstract][Full Text] [Related]
3. Activation of the complement system by antibody-antigen complexes: the classical pathway.
Porter RR; Reid KB
Adv Protein Chem; 1979; 33():1-71. PubMed ID: 396780
[No Abstract] [Full Text] [Related]
4. The functional inhibition of activated C1 inhibitor in normal human serum causes spontaneous consumption of the complement components C2, C3, C4, and factor B.
Gronski P; Bodenbender L; Kanzy EJ; Piepenbrock M; Seiler FR
Immunobiology; 1986 Apr; 171(3):252-62. PubMed ID: 3011651
[TBL] [Abstract][Full Text] [Related]
5. Effect of aspirin on the complement system in vitro.
Hänsch GM; Voigtländer V; Rother U
Int Arch Allergy Appl Immunol; 1980; 61(2):150-8. PubMed ID: 7351347
[TBL] [Abstract][Full Text] [Related]
6. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
Fearon DT; Austen KF; Ruddy S
Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
[No Abstract] [Full Text] [Related]
7. C3 nephritic factor stabilization of the classic C3 convertase: a role for C2 in C3 nephritic factor activity.
McLean RH; Nilson SH
Proc Soc Exp Biol Med; 1979 Jul; 161(3):358-63. PubMed ID: 461464
[No Abstract] [Full Text] [Related]
8. [Proteases in complement system (author's transl)].
Nagasawa S
Tanpakushitsu Kakusan Koso; 1980; 25(6):531-46. PubMed ID: 7010425
[No Abstract] [Full Text] [Related]
9. Formation and function of the classical and alternative pathways of complement.
Ogle JD; Ogle CK
Clin Physiol Biochem; 1983; 1(2-5):194-213. PubMed ID: 6241120
[No Abstract] [Full Text] [Related]
10. The reactivity of the complement system.
Hadding U
Monogr Allergy; 1977; 12():36-45. PubMed ID: 335218
[No Abstract] [Full Text] [Related]
11. Interactions between the alternative complement pathway and proteases of the coagulation system.
Kazatchkine MD; Jouvin MH
Adv Exp Med Biol; 1984; 167():235-9. PubMed ID: 6561912
[No Abstract] [Full Text] [Related]
12. [Complement activation and biological activities].
Inoue K
Nihon Saikingaku Zasshi; 1976 Jul; 31(4):535-55. PubMed ID: 988219
[No Abstract] [Full Text] [Related]
13. Methods to detect and quantitate complement activation.
Cooper NR; Nemerow GR; Mayes JT
Springer Semin Immunopathol; 1983; 6(2-3):195-212. PubMed ID: 6195745
[No Abstract] [Full Text] [Related]
14. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.
Gigli I; Sorvillo J; Mecarelli-Halbwachs L; Leibowitch J
J Exp Med; 1981 Jul; 154(1):1-12. PubMed ID: 7019379
[TBL] [Abstract][Full Text] [Related]
15. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
16. Structure and activation of the early components of complement.
Porter RR
Fed Proc; 1977 Aug; 36(9):2191-6. PubMed ID: 328305
[No Abstract] [Full Text] [Related]
17. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
Geiger H; Good RA; Day NK
Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
[TBL] [Abstract][Full Text] [Related]
18. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.
Nicholson-Weller A; Burge J; Fearon DT; Weller PF; Austen KF
J Immunol; 1982 Jul; 129(1):184-9. PubMed ID: 6211481
[No Abstract] [Full Text] [Related]
19. Complement activation in acute glomerulonephritis in children.
Levy M; Sich M; Pirotzky E; Habib R
Ric Clin Lab; 1980; 10(1):87-91. PubMed ID: 7008160
[No Abstract] [Full Text] [Related]
20. Human complement proteins D, C2, and B. Active site mapping with peptide thioester substrates.
Kam CM; McRae BJ; Harper JW; Niemann MA; Volanakis JE; Powers JC
J Biol Chem; 1987 Mar; 262(8):3444-51. PubMed ID: 3546307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]